Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008, 152(1):163-168 | DOI: 10.5507/bp.2008.027

POOR SURVIVAL OF ABG I HIP PROSTHESIS IN YOUNGER PATIENTS

Jiri Galloa, Katerina Langovab, Vitezslav Havranekc, Ivana Cechovaa
a Department of Orthopedics, Teaching Hospital and Faculty of Medicine and Dentistry, Palacky University, I. P. Pavlova 6, Olomouc, Czech Republic
b Department of Biometry, Faculty of Medicine and Dentistry, Palacky University, Olomouc
c Joint Laboratory of Optics, Palacky University & Academy of Sciences of the Czech Republic, Olomouc

Background: Hydroxyapatite coated (HAC) hip implants have been used in clinical practice for more than two decades. However, the majority of studies have reported only intermediate term outcomes that are not reliable for predicting long-term behavior in all implants. The aim of this study was to determine the performance of HAC total hip arthroplasty in younger patients over a 10-year follow-up period.

Methods and Results: This was an observational retrospective study of a 137 consecutive hips with the ABG I prosthesis. Of these, 128 were available for the last investigation. Median duration of follow-up was 10.9 years. The mean age at time of index surgery was 46±6.7 years. Probability of implant survival was estimated using the Kaplan-Meier method. The overall 12-year cumulative survival was 0.55 (95% CI, 0.443-0.659). Periprosthetic osteolysis (57 %) was the most frequent reason for failure followed by aseptic loosening (28 %). When only aseptic loosening was included in the analysis, the same figures for cup and stem were 0.873 (95% CI, 0.808-0.938) and 0.992 (95% CI, 0.976- 1.0), respectively. Patients with a smaller cup size were those at high risk for revision due to wear-related complications (odds ratio, OR=4.3; 95% CI, 1.734-10.555).

Conclusion: This study reports one of the poorest 12-year survivorship data for cementless acetabular component in the literature. The main reason for premature failure was osteolysis, strongly related to high wear rate of polyethylene.

Keywords: Keywords: Total hip arthroplasty, ABG I, Survival analysis, Hydroxyapatite coating, Osteolysis

Received: March 15, 2008; Accepted: May 5, 2008; Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Gallo, J., Langova, K., Havranek, V., & Cechova, I. (2008). POOR SURVIVAL OF ABG I HIP PROSTHESIS IN YOUNGER PATIENTS. Biomedical papers152(1), 163-168. doi: 10.5507/bp.2008.027
Download citation

References

  1. Dumbleton J, Manley MT. Hydroxyapatite-coated prostheses in total hip and knee arthroplasty. J Bone Joint Surg Am 2004; 86:2526- 40. Go to original source... Go to PubMed...
  2. von Schewelov T, Sanzen L, Onsten I, Carlsson A. Catastrophic failure of an uncemented acetabular component due to high wear and osteolysis: an analysis of 154 omnifi t prostheses with mean 6-year follow-up. Acta Orthop Scand 2004; 75:283-94. Go to original source... Go to PubMed...
  3. Reikeras O, Gunderson RB. Failure of HA coating on a gritblasted acetabular cup: 155 patients followed for 7-10 years. Acta Orthop Scand 2002; 73:104-8. Go to original source... Go to PubMed...
  4. Tonino AJ, Rahmy AI. The hydroxyapatite-ABG hip system: 5- to 7-year results from an international multicentre study. The International ABG Study Group. J Arthroplasty 2000; 15:274-82. Go to original source... Go to PubMed...
  5. Gallo J, Kaminek P, Zapletalova J, Novotny R, Cechova I, Ditmar R. Early failure of the polyethylene liner in the ABG I total hip prosthesis. Acta Chir Orthop Traumatol Cech 2003; 70:343-9. Go to PubMed...
  6. Rogers A, Kulkarni R, Downes EM. The ABG hydroxyapatitecoated hip prosthesis: one hundred consecutive operations with average 6-year follow-up. J Arthroplasty 2003; 18:619-25. Go to original source... Go to PubMed...
  7. Giannikas KA, Din R, Sadiq S, Dunningham TH. Medium-term results of the ABG total hip arthroplasty in young patients. J Arthroplasty 2002; 17:184-8. Go to original source... Go to PubMed...
  8. Hartofi lakidis G, Karachalios T. Total hip arthroplasty for congenital hip disease. J Bone Joint Surg Am 2004; 86:242-50. Go to original source... Go to PubMed...
  9. Gallo J, Havranek V, Cechova I, Zapletalova J. Infl uence of demographic, surgical and implant variables on wear rate and osteolysis in ABG I hip arthroplasty. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150:135-41. Go to original source... Go to PubMed...
  10. Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fi xation of porous-surfaced femoral components. Clin Orthop Relat Res 1990; 257:107-28. Go to original source... Go to PubMed...
  11. Udomkiat P, Wan Z, Dorr LD. Comparison of preoperative radiographs and intraoperative fi ndings of fi xation of hemispheric porous- coated sockets. J Bone Joint Surg Am 2001; 83-A:1865-70. Go to original source... Go to PubMed...
  12. Sachs L. Applied statistics. Heidelberg:Springer-Verlag;1984. Go to original source...
  13. Badhe S, Livesley P. Early polyethylene wear and osteolysis with ABG acetabular cups (7- to 12-year follow-up). Int Orthop 2006; 30:31-34. Go to original source... Go to PubMed...
  14. Kim WY, Muddu BN. Eleven-year results of the ABG I hip replacement. Int Orthop 2006; 30:182-84. Go to original source... Go to PubMed...
  15. Oosterbos CJ, Rahmy AI, Tonino AJ, Witpeerd W. High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years. Acta Orthop Scand 2004; 75:127-33. Go to original source... Go to PubMed...
  16. Canales Cortes V, Panisello Sebastia JJ, Herrera Rodriguez A, Peguero Bona A, Martinez Martin A, Herrero-Barcos L. et al. Ten-year follow-up of an anatomical hydroxyapatite-coated total hip prosthesis. Int Orthop 2006; 30:84-90. Go to original source... Go to PubMed...
  17. Castoldi F, Rossi R, La Russa M, Sibelli P, Rossi P, Ranawat AS. Ten-year survivorship of the Anatomique Benoist Girard I total hip arthroplasty. J Arthroplasty 2007; 22:363-68. Go to original source... Go to PubMed...
  18. Kurtz SM, Rimnac CM, Hozack WJ, Turner J, Marcolongo M, Goldberg VM. et al. In vivo degradation of polyethylene liners after gamma sterilization in air. J Bone Joint Surg Am 2005; 87:815- 23. Go to original source... Go to PubMed...
  19. Kurtz SM, Harrigan TP, Herr M, Manley MT. An in vitro model for fl uid pressurization of screw holes in metal-backed total joint components. J Arthroplasty 2005; 20:932-38. Go to original source... Go to PubMed...
  20. Schmalzried TP, Huk OL. Patient factors and wear in total hip arthroplasty. Clin Orthop Relat Res 2004; 418:94-97. Go to original source... Go to PubMed...
  21. Herrera A, Canales V, Anderson J, Garcia-Araujo C, Murcia- Mazon A, Tonino AJ. Seven to 10 years followup of an anatomic hip prosthesis: an international study. Clin Orthop Relat Res 2004; 423:129-37. Go to original source... Go to PubMed...
  22. Chougle A, Hemmady MV, Hodgkinson JP. Severity of hip dysplasia and loosening of the socket in cemented total hip replacement. A long-term follow-up. J Bone Joint Surg Br 2005; 87:16-20. Go to original source...
  23. Utting MR, Lankester BJ, Smith LK, Spencer RF. Total hip replacement and NICE. BMJ 2005; 330:318-19. Go to original source... Go to PubMed...
  24. Garellick G, Malchau H, Herberts P. Survival of hip replacements. A comparison of a randomized trial and a registry. Clin Orthop Relat Res 2000; 375:157-67. Go to original source... Go to PubMed...
  25. Herberts P, Malchau H. How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop Relat Res 1997; 344:44-60. Go to original source... Go to PubMed...